SNTI logo

Senti Biosciences (SNTI)

Profile

Full Name

Senti Biosciences, Inc.

Ticker Symbol

SNTI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 26, 2021

Indexes

Not included

Website

http://www.sentibio.com

Employees

34

Key Details

Price

$3.88(+1.04%)

Market cap

$100.90M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$12.03(+24.86% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.88
SNTI price is $3.88

30-Day Relative Volume

0.35
SNTI 30-day relative volume is 0.35

Price Performance

Price Most recent change

+1.04%
SNTI price was up +1.04% on Apr 17, 2025

Price YTD change

+10.54%
SNTI price is up +10.54% since January 1st

Price 1-year change

+25.16%
SNTI price is up +25.16% year-on-year

Price 3-year change

-96.1%
SNTI price is down -96.1% over the past 3 years

Price Range

Price All-time high

$102.40
SNTI price is currently -96.21% below its historical high of $102.40

Price 3-year low

$0.21
SNTI price is currently +1738.86% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$100.90M
SNTI market capitalization is $100.90 million

Market cap 3-year change

-
SNTI market capitalization 3-year change is unknown

Market cap All-time high

$284.53M
SNTI market capitalization is currently -64.54% below its historical high of $284.53 million

Market cap sector rank

48.52%
SNTI market capitalization is higher than 48.52% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+468.86%
SNTI shares outstanding is up +468.86% year-on-year

Shares Outstanding 3-Year Change

-
SNTI shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.12
SNTI beta is 1.12

200-day SMA

$3.22
SNTI price is currently +20.31% above its 200-day simple moving average

50-day SMA

$3.55
SNTI price is currently +9.22% above its 50-day simple moving average

RSI

60.43
SNTI 14-day relative strength index is 60.43

Volume

0.35
SNTI 30-day relative volume is 0.35

ATR

$0.38
SNTI average true range is $0.38

10-day Historical Volatility

99.98%
SNTI 10-day historical volatility is 99.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SNTI annual revenue value is unknown

Revenue Analysts estimate

$5.00M
SNTI annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
SNTI annual revenue 1-year change is unknown

Revenue Sector rank

-
SNTI annual revenue is unknown

EPS

EPS

-$12.03
SNTI annual earnings per share is -$12.03

EPS Analysts estimate

-$1.88
SNTI annual earnings per share is currently +539.89% higher than the consensus analysts' forecast

EPS 1-year change

+24.86%
SNTI annual earnings per share is up +24.86% year-on-year

EPS Sector rank

10.33%
SNTI annual earnings per share is higher than 10.33% of companies in Healthcare sector

Profit

Gross profit

-
SNTI annual gross profit value is unknown

Gross margin

-
SNTI annual gross profit margin value is unknown

Operating profit

-$60.73M
SNTI annual operating income is -$60.73 million

Operating margin

-
SNTI annual operating profit margin value is unknown

Net income

-$52.79M
SNTI annual net profit is -$52.79 million

Net margin

-
SNTI annual net profit margin value is unknown

Expenses

Total expenses

$60.73M
SNTI annual total expenses is $60.73 million

Operating expenses

$60.73M
SNTI annual total operating expenses is $60.73 million

Cost of goods sold

-
SNTI annual cost of goods sold value is unknown

Selling, general & administrative expenses

$23.51M
SNTI annual SGA is $23.51 million

Depreciation and amortization

$5.85M
SNTI annual depreciation & amortization is $5.85 million

Interest expense

-
SNTI annual interest expense value is unknown

Income tax

-
SNTI annual income tax value is unknown

EBIT & EBITDA

EBIT

-$60.73M
SNTI annual earnings before interest & taxes is -$60.73 million

EBITDA

-$54.88M
SNTI annual EBITDA is -$54.88 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$97.84M
SNTI annual total assets is $97.84 million

Non current assets

$38.88M
SNTI annual long term assets is $38.88 million

Current assets

$58.96M
SNTI annual total current assets is $58.96 million

Cash and cash equivalents

$48.28M
SNTI annual cash & cash equivalents is $48.28 million

Accounts receivable

$159.00K
SNTI annual accounts receivable is $159.00 thousand

Inventory

-
SNTI annual inventory value is unknown

Liabilities

Total liabilities

$72.19M
SNTI annual total liabilities is $72.19 million

Long term liabilities

$59.05M
SNTI annual total long term liabilities is $59.05 million

Current liabilities

$13.15M
SNTI annual total current liabilities is $13.15 million

Accounts payable

$1.45M
SNTI annual accounts payable is $1.45 million

Debt

Total debt

$33.64M
SNTI annual total debt is $33.64 million

Total debt 1-year change

-10.69%
SNTI annual total debt is down -10.69% year-on-year

Long term debt

$28.89M
SNTI annual long term debt is $28.89 million

Short term debt

$4.75M
SNTI annual short term debt is $4.75 million

Equity & Capital

Shareholders equity

$25.65M
SNTI annual stockholders equity is $25.65 million

Book value

$25.65M
SNTI annual book value is $25.65 million

Retained earnings

-$297.13M
SNTI annual retained earnings is -$297.13 million

Working capital

$45.81M
SNTI annual working capital is $45.81 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$41.40M
SNTI annual cash flow from operations is -$41.40 million

Cash from operations 1-year change

+20.99%
SNTI annual cash flow from operations is up +20.99% year-on-year

Cash from investing

$34.00K
SNTI annual cash flow from investing activities is $34.00 thousand

Cash from investing 1-year change

-99.89%
SNTI annual cash flow from investing activities is down -99.89% year-on-year

Cash from financing

$53.73M
SNTI annual cash flow from financing activities is $53.73 million

Cash from financing 1-year change

+6797.3%
SNTI annual cash flow from financing activities is up +6797.3% year-on-year

CAPEX

CAPEX

-
SNTI annual capital expenditures value is unknown

CAPEX 1-year change

-
SNTI annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$41.42M
SNTI annual free cash flow is -$41.42 million

Free cash flow 1-year change

+35.71%
SNTI annual free cash flow is up +35.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SNTI annual gross profit margin value is unknown

Operating margin

-
SNTI annual operating profit margin value is unknown

Net margin

-
SNTI annual net profit margin value is unknown

ROA & ROE

ROA

-53.95%
SNTI annual return on assets is -53.95%

ROE

-205.82%
SNTI annual return on equity is -205.82%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SNTI price to earnings ratio value is unknown

PE ratio Sector rank

-
SNTI price to earnings ratio is unknown

PB Ratio

PB ratio

3.93
SNTI price to book ratio is 3.93

PB ratio Sector rank

78.91%
SNTI price to book ratio is higher than 78.91% of companies in Healthcare sector

PS Ratio

PS ratio

-
SNTI price to sales ratio value is unknown

PS ratio Sector rank

-
SNTI price to sales ratio is unknown

Enterprise value

Enterprise value

$86.26M
SNTI enterprise value is $86.26 million

Enterprise value Sector rank

48.14%
SNTI enterprise value is higher than 48.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.57
SNTI EV/EBITDA is -1.57

EV/EBITDA Sector rank

36.43%
SNTI EV/EBITDA is higher than 36.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.49
SNTI annual current ratio is 4.49

Quick ratio

-
SNTI annual quick ratio value is unknown

Leverage

Debt to equity

1.31
SNTI annual debt to equity ratio is 1.31

Interest coverage ratio

-
SNTI annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SNTI piotroski f-score value is unknown

Altman Z-Score

-
SNTI altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 4, 24 Chardan Capital
Buy
Dec 2, 24 Chardan Capital
Buy
Aug 15, 23 Chardan Capital
Buy
May 11, 23 Chardan Capital
Buy
Mar 24, 23 Morgan Stanley
Equal-Weight
Mar 23, 23 Chardan Capital
Buy
Jan 30, 23 Chardan Capital
Buy
Jan 27, 23 Morgan Stanley
Equal-Weight
Dec 16, 22 JP Morgan
Neutral
Oct 7, 22 Morgan Stanley
Equal-Weight

Institutional Ownership

Similar stocks

TIL logo
Instil Bio (TIL)
TNXP logo
Tonix Pharmaceuticals Holding (TNXP)
AIRS logo
AirSculpt Technologies (AIRS)
PROK logo
ProKidney (PROK)
Genelux (GNLX)
INFU logo
InfuSystem Holdings (INFU)
Anteris Technologies Global (AVR)
RPID logo
Rapid Micro Biosystems (RPID)
BTMD logo
biote (BTMD)
  • What is the ticker symbol for Senti Biosciences?
  • Does Senti Biosciences pay dividends?
  • What sector is Senti Biosciences in?
  • What industry is Senti Biosciences in?
  • What country is Senti Biosciences based in?
  • When did Senti Biosciences go public?
  • Is Senti Biosciences in the S&P 500?
  • Is Senti Biosciences in the NASDAQ 100?
  • Is Senti Biosciences in the Dow Jones?
  • When was Senti Biosciences's last earnings report?
  • When does Senti Biosciences report earnings?
  • Should I buy Senti Biosciences stock now?

What is the ticker symbol for Senti Biosciences?

The ticker symbol for Senti Biosciences is NASDAQ:SNTI

Does Senti Biosciences pay dividends?

No, Senti Biosciences does not pay dividends

What sector is Senti Biosciences in?

Senti Biosciences is in the Healthcare sector

What industry is Senti Biosciences in?

Senti Biosciences is in the Biotechnology industry

What country is Senti Biosciences based in?

Senti Biosciences is headquartered in United States

When did Senti Biosciences go public?

Senti Biosciences's initial public offering (IPO) was on May 26, 2021

Is Senti Biosciences in the S&P 500?

No, Senti Biosciences is not included in the S&P 500 index

Is Senti Biosciences in the NASDAQ 100?

No, Senti Biosciences is not included in the NASDAQ 100 index

Is Senti Biosciences in the Dow Jones?

No, Senti Biosciences is not included in the Dow Jones index

When was Senti Biosciences's last earnings report?

Senti Biosciences's most recent earnings report was on Mar 20, 2025

When does Senti Biosciences report earnings?

The next expected earnings date for Senti Biosciences is May 9, 2025

Should I buy Senti Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page